Price loading...

Antibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer: 17 (AAPS Advances in the Pharmaceutical Sciences Series, 17)

Price data last checked 109 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Description

The field of antibody-drug conjugates (ADCs) has undergone remarkable advancements in recent years, marked by significant progress in both drug approvals and ongoing clinical development. Since the approval of the first ADC in 2010 (gemtuzumab ozogamicin, Mylotarg®), the landscape has expanded dramatically. Today, there are 11 FDA-approved ADCs, targeting a variety of cancers across multiple indications. The approved ADCs include a range of payloads, linkers, and antibodies, each optimized for a variety of specific therapeutic targets. The increasing diversity of ADCs reflects the growing potential of these innovative treatments to address a wide array of malignancies, from hematologic cancers to solid tumors. This book aims to provide a comprehensive overview of the current state of the ADC field including the latest developments, challenges, and emerging trends, comprising expertise from a broad range of disciplines from basic research, industry, clinical practice and regulatory affairs. We explore not only the scientific and technical aspects of ADC design―such as payloads, linkers, and antibody selection―but also the developmental hurdles and regulatory complexities that influence the success of ADCs in clinical practice. Real-world examples of ADCs that have made it from the lab to the clinic offer invaluable insights into the trials and triumphs that shape this dynamic field. It is our hope that this book will serve as both a valuable resource for experts in the field and an accessible introduction for those new to the exciting world of ADCs.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
16 April 2025
Listed Since
10 December 2024

Barcode

No barcode data available

Similar Products You Might Like

Humana Antibody-Drug Conjugates and Immunotoxins Book
95% match

Humana Antibody-Drug Conjugates and Immunotoxins Book

Humana

£107.43 03 Mar 2026
Innovations for Next-Generation Antibody-Drug Conjugates (Cancer Drug Discovery and Development)
95% match

Innovations for Next-Generation Antibody-Drug Conjugates (Cancer Drug Discovery and Development)

Humana

£107.43 07 Mar 2026
Springer - Novel Immunotherapeutic Approaches to Cancer Treatment
94% match

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Springer

£108.91 20 Apr 2026
Springer - Novel Immunotherapeutic Approaches to Cancer Treatment
94% match

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Springer

£113.48 18 Apr 2026
Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)
94% match

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Humana

£147.91 10 Mar 2026
Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)
94% match

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Humana

£117.40 15 Jan 2026
Pharmaceutical Perspectives of Cancer Therapeutics
93% match

Pharmaceutical Perspectives of Cancer Therapeutics

Springer

£139.95 11 Jan 2026
Targeted Cancer Immune Therapy
93% match

Targeted Cancer Immune Therapy

Springer

£145.51 11 Jan 2026
Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)
93% match

Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)

£179.10 13 Jan 2026
Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)
93% match

Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)

Springer

£160.00 13 Jan 2026
Current Applications of Pharmaceutical Biotechnology: 171 (Advances in Biochemical Engineering/Biotechnology, 171)
93% match

Current Applications of Pharmaceutical Biotechnology: 171 (Advances in Biochemical Engineering/Biotechnology, 171)

£271.91 08 Jan 2026
Current Applications of Pharmaceutical Biotechnology: 171 (Advances in Biochemical Engineering/Biotechnology, 171)
93% match

Current Applications of Pharmaceutical Biotechnology: 171 (Advances in Biochemical Engineering/Biotechnology, 171)

Springer

£240.00 13 Jan 2026
Successes and Challenges of NK Immunotherapy: Breaking Tolerance to Cancer Resistance
93% match

Successes and Challenges of NK Immunotherapy: Breaking Tolerance to Cancer Resistance

Academic Press

£98.89 09 Mar 2026
Advances in Nutraceutical Applications in Cancer: Recent Research Trends and Clinical Applications: Recent Research Trends and Clinical Applications
93% match

Advances in Nutraceutical Applications in Cancer: Recent Research Trends and Clinical Applications: Recent Research Trends and Clinical Applications

CRC Press

£180.00 09 Mar 2026
Immunopharmacology
93% match

Immunopharmacology

Springer

£92.56 26 Feb 2026
Advances in Cancer Treatment: From Systemic Chemotherapy to Targeted Therapy
93% match

Advances in Cancer Treatment: From Systemic Chemotherapy to Targeted Therapy

Springer

£54.12 08 Mar 2026
Springer - Nanomedicine for Cancer Diagnosis and Therapy
93% match

Springer - Nanomedicine for Cancer Diagnosis and Therapy

Springer

£121.23 18 Apr 2026
Antibody-Drug Conjugates: 1045 (Methods in Molecular Biology, 1045)
93% match

Antibody-Drug Conjugates: 1045 (Methods in Molecular Biology, 1045)

Humana

£80.09 02 Mar 2026
Chemistry and Pharmacology of Anticancer Drugs
93% match

Chemistry and Pharmacology of Anticancer Drugs

CRC Press

£192.76 17 Apr 2026
CRC Press - Chemistry and Pharmacology of Anticancer Drugs
93% match

CRC Press - Chemistry and Pharmacology of Anticancer Drugs

CRC Press

£133.99 15 Apr 2026
Nanocarriers for Drug Delivery: Concepts and Applications (Nanomedicine and Nanotoxicology)
93% match

Nanocarriers for Drug Delivery: Concepts and Applications (Nanomedicine and Nanotoxicology)

Springer

£130.65 10 Feb 2026
Springer - Immunotherapy of Cancer: An Innovative Treatment
93% match

Springer - Immunotherapy of Cancer: An Innovative Treatment

Springer

£110.34 18 Apr 2026
Medicines for Cancer: Mechanism of Action and Clinical Pharmacology of Chemo, Hormonal, Targeted, and Immunotherapies
92% match

Medicines for Cancer: Mechanism of Action and Clinical Pharmacology of Chemo, Hormonal, Targeted, and Immunotherapies

£131.36 14 Jan 2026
Cancer Immunotherapy: Immune Suppression and Tumor Growth
92% match

Cancer Immunotherapy: Immune Suppression and Tumor Growth

Academic Press

£77.00 24 Feb 2026